More work will be needed to identify the precise mechanisms underlying the effects of BET inhibition on fibrosis, but altogether, our results lend further support to the idea that BET inhibition may be an effective treatment for fibrosis in NASH. The gene discussed is DNER; the disease is metabolic dysfunction-associated steatohepatitis.